1-6 of 6
Michael S. O'Reilly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measuring response to antiangiogenic agents

Free
Michael S. O'Reilly
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): PL-40.
Published: 15 August 2014
View articletitled, Measuring response to antiangiogenic agents
Journal Articles

Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis

Free
Osamu Takahashi, Ritsuko Komaki, Paul D. Smith, Juliane M. Jürgensmeier, Anderson Ryan, B. Nebiyou Bekele, Ignacio I. Wistuba, Jörg J. Jacoby, Maria V. Korshunova, Anna Biernacka, Baruch Erez, Keiko Hosho, Roy S. Herbst, Michael S. O'Reilly
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1641–1654.
https://doi.org/10.1158/1078-0432.CCR-11-2324
Published: 14 March 2012
View articletitled, Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis
Open the PDF for Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis in another window
Journal Articles

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Does Not Improve Paclitaxel Effect in an Orthotopic Mouse Model of Lung Cancer

Free
Amir Onn, Takeshi Isobe, Wenjuan Wu, Satoshi Itasaka, Tomoaki Shintani, Keiko Shibuya, Yokoi Kenji, Michael S. O’Reilly, Isaiah J. Fidler, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8613–8619.
https://doi.org/10.1158/1078-0432.CCR-04-1241
Published: 28 December 2004
View articletitled, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Does Not Improve Paclitaxel Effect in an Orthotopic Mouse Model of Lung Cancer
Open the PDF for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Does Not Improve Paclitaxel Effect in an Orthotopic Mouse Model of Lung Cancer in another window
Journal Articles

Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2- neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

Free
Amir Onn, Arlene M. Correa, Michael Gilcrease, Takeshi Isobe, Erminia Massarelli, Corazon D. Bucana, Michael S. O’Reilly, Waun K. Hong, Isaiah J. Fidler, Joe B. Putnam, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (1): 136–143.
https://doi.org/10.1158/1078-0432.CCR-0373-3
Published: 20 January 2004
View articletitled, Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2- neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
Open the PDF for Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2- neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer in another window
Journal Articles

Development of an Orthotopic Model to Study the Biology and Therapy of Primary Human Lung Cancer in Nude Mice

Free
Amir Onn, Takeshi Isobe, Satoshi Itasaka, Wenjuan Wu, Michael S. O’Reilly, Waun Ki Hong, Isaiah J. Fidler, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5532–5539.
Published: 03 December 2003
View articletitled, Development of an Orthotopic Model to Study the Biology and Therapy of Primary Human Lung Cancer in Nude Mice
Open the PDF for Development of an Orthotopic Model to Study the Biology and Therapy of Primary Human Lung Cancer in Nude Mice in another window
Journal Articles

Targeting Multiple Biological Pathways as a Strategy to Improve the Treatment of Cancer

Free
Michael S. O’Reilly
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3309–3310.
Published: 01 November 2002
View articletitled, Targeting Multiple Biological Pathways as a Strategy to Improve the Treatment of Cancer
Open the PDF for Targeting Multiple Biological Pathways as a Strategy to Improve the Treatment of Cancer in another window